Ecoendoscopy in cancer of the pancreas

November 24, 2005

Cancer of the pancreas is the number five in the list of deaths due to cancers in Spain and the third causing deaths due to digestive tumour. Moreover, the survival rate for patients with which it is possible to carry out a complete resection of the tumour does not reach 25% within five years. This is because, although good localised control, metastasis occurs, the principal cause of death in cancer of the pancreas.

Over the last few years the approach to this disease has improved considerably thanks to developments in ecoendoscopy. This involves a technique which gives importance to the diagnosis and treatmeant of the pancreatic pathology. Nevertheless, for the moment, the technique has not been introduced into hospitals in Spain in a general manner. The University Hospital of Navarra is one of the few centres that provide this service.

Advantages

Ecoendoscopy, on the one hand, characterises the morphology and the type of tumour with precision. Moreover, it is particularly efficacious for carrying out precise locoregional stratification, thus enabling the selection of the most suitable treatment for each case and rescue patients that, with other image-generating methods, were referred for palliative treatments.

Also, from a therapeutic perspective, ecoendoscopy is becoming increasingly important, playing an important role in the treatment of pain arising pancreatic pathology and it is currently being used in novel therapies such as genic therapy.
-end-


Elhuyar Fundazioa

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.